期刊文献+

头痛宁胶囊治疗偏头痛60例疗效观察 被引量:2

Toutongning capsule treatment of migraine in 60 cases
下载PDF
导出
摘要 目的观察头痛宁胶囊防治偏头痛的疗效。方法将120例门诊偏头痛患者随机分为对照组和治疗组,每组60例,对照组采用西比灵口服治疗,治疗组采用头痛宁胶囊治疗,两组均以4周为1个疗程。治疗前后观察2组在头痛持续时间、发作频率、头痛强度等方面的改善情况,并比较疗效。结果经过1个疗程的治疗,总有效率治疗组为91.7%,对照组为66.7%,2组比较差异有统计学意义(P<0.05)。结论头痛宁胶囊口服治疗偏头痛,在减轻头痛程度、缩短头痛持续时间等方面疗效较好,且无明显的不良反应。 Objective To observe the curative effect of Toutongning capsule for the treatment of the migraine. Methods 120 outpatients with migraine were randomly divided into control group and treatment group, each with 60 cases. The control group was given Sibelium capsule oral treatment, while the treatment group was given Toutongning capsule treatment. The two groups were given four weeks for a course of treatment. Before and after treatment, the improvement of headache duration, attack frequency, headache intensity and the efficacy were observed and compared for two groups. Results After a course of treatment, the total efficiency of the treatment group was 91.7%, while it is 66.7% in the control group. The difference was significant (P(0. 05). Conclusion Toutongning capsule oral treatment is better in reducing headache extent, and in decreasing the headache duration and other terms of efficacy, when compared with Sibelium capsule oral treatment. And it has no significant side effects.
出处 《国外医学(医学地理分册)》 CAS 2012年第2期123-124,共2页 Foreign Medical Sciences:Section of Medgeography
关键词 偏头痛 头痛宁胶囊 西比灵 migraine toutongning capsule sibelium
  • 相关文献

参考文献4

二级参考文献22

  • 1王静怡,Yasuhiro Magata,Naoya Hattori,Yoshiharu Yonekura,Nagara Tamaki,Fumiko Tanaka,Junji Konishi,Seok Rye Choi,Shigeru Matsuzaki.OBSERVATION ON THE EFFECTS OF CHINESE MEDICINE ZHENXUANYIN FOR IMPROVING CEREBRAL BLOOD FLOW IN RATS WITH CEREBRAL ISCHEMIA[J].Journal of Traditional Chinese Medicine,1997,17(4):299-303. 被引量:2
  • 2陶陶,徐坚,董佑忠,黄能慧,李玲,李诚秀.电针及天麻对大鼠脑缺血再灌注后神经细胞凋亡及相关蛋白Bcl-2、Bax表达的影响[J].中国针灸,2004,24(9):645-648. 被引量:20
  • 3中华医学会头面痛专业委员会.偏头痛程度分级评价方案[Z].,1994.23.
  • 4Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society [J]. Cephalalgia, 1988, 8 (suppl 7) : 1 - 96.
  • 5Lipton RB,Diamond S,Reed M,et al.Migraine diagnosis and treatment:results from the American Migraine Study Ⅱ.Headache,2001,41:638-645.
  • 6Silberstein SD.Practice parameter:evidence-based guidelines for migraine headache (an evidence-based review):report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology,2000,55:754-762.
  • 7Ferrari MD,Roon KI,Lipton RB,et al.Oral triptans (serotonin 5-HT(1B/1 D) agonists) in acute migraine treatment:a meta-analysis of 53 trials/ Lancet,2001,358:1668-1675.
  • 8Headache Classification Subcommittee of the International Headache Society.The Internatiional Classificatiion of Headache Disorders:2nd edition.Cephalalgia,2004,24 Suppl 1:9-160.
  • 9Lawrence EC.Diagnosis and management of migraine headaches.South Med J,2004,97:1069-1077.
  • 10Goadsby PJ,Lipton RB,Ferrari MD.Migraine-current understanding and treatment.N Engl J Med,2002,346:257-270.

共引文献374

同被引文献40

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部